This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Flamel Undisclosed UMD #4
Drug Names(s): Éclat Drug #4
This compound was originally developed by Éclat Pharmaceuticals.
Flamel stated that it plans to file an NDA for a fourth undisclosed compound. BioMedTracker will update this profile when further information becomes available.
Flamel and clat
In March 2012, Flamel Technologies acquired clat Pharmaceuticals.
Additional information available to subscribers only: